Leonard S. Schleifer
2019
Compensation breakdown
Non-Equity Incentive Plan | $3,057,162 |
---|---|
Option Awards | $11,699,586 |
Salary | $1,377,100 |
Stock Awards | $4,983,226 |
Other | $338,043 |
Total | $21,455,117 |
Schleifer received $11.7M in option awards, accounting for 55% of the total pay in 2019.
Schleifer also received $3.1M in non-equity incentive plan, $1.4M in salary, $5M in stock awards and $338K in other compensation.
Rankings
In 2019, Leonard S. Schleifer's compensation ranked 126th out of 13,971 executives tracked by ExecPay. In other words, Schleifer earned more than 99.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 126 | 99th |
Manufacturing | 46 | 99th |
Chemicals And Allied Products | 10 | 100th |
Drugs | 9 | 100th |
Pharmaceutical Preparations | 8 | 99th |
Schleifer's colleagues
We found four more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2019.
2019
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2019
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2019
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
2019
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
News
April 21, 2022
April 23, 2021
April 24, 2020
April 26, 2019